| Lipid Mediators in Immune Dysfunction after Severe Inflammation|
Recent data indicate the potential efficacy of therapeutic interventions that either reduce immunosuppressive prostaglandins (PGs) or increase specialized proresolving lipid mediators (LMs). In this review, the authors reassess the potential for pharmacological manipulation of these LMs as therapeutic approaches for the treatment of critical illness. [Trends Immunol] Abstract
Visit our reviews page to see a complete list of reviews in the human immunology research field.